SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-125560
Filing Date
2022-04-28
Accepted
2022-04-28 08:32:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d268305ddefa14a.htm DEFA14A 10203
2 GRAPHIC g268305dsp053.jpg GRAPHIC 266035
3 GRAPHIC g268305dsp054.jpg GRAPHIC 153042
  Complete submission text file 0001193125-22-125560.txt   588683
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39979 | Film No.: 22862433
SIC: 2836 Biological Products, (No Diagnostic Substances)